Lisa M. Shewchuk

5.2k citations

45 papers · 3.0k indexed · 1 hit paper · h-index 27

Oncology top 5%
- HER2/EGFR in Cancer Research 4
- Cancer-related Molecular Pathways 4
Organic Chemistry top 5%
Molecular Biology top 5%
- Bone Metabolism and Diseases 8
- Signaling Pathways in Disease 6
- Natural product bioactivities and synthesis 5
- Protein Kinase Regulation and GTPase Signaling 4
Computational Theory and Mathematics top 2%
Cell Biology top 5%
Materials Chemistry
- Enzyme Structure and Function 5
Immunology and Allergy
- Cell Adhesion Molecules Research 4

Co-authors: Anne M. Hassell Byron Ellis David W. Rusnak Edgar R. Wood Anne T. Truesdale Krystal J. Alligood Tona M. Gilmer Karen Lackey
Cited by: Oncology Organic Chemistry Molecular Biology
Journals: Cell (1 paper)Proceedings of the National Academy of Sciences (1 paper)PLoS ONE (1 paper)
Partner nations: United States Japan Canada

In The Last Decade

Lisa M. Shewchuk

45 papers receiving 2.9k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Lisa M. Shewchuk

Since Specialization

Citations

This map shows the geographic impact of Lisa M. Shewchuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa M. Shewchuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa M. Shewchuk more than expected).

Fields of papers citing papers by Lisa M. Shewchuk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa M. Shewchuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa M. Shewchuk. The network helps show where Lisa M. Shewchuk may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lisa M. Shewchuk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lisa M. Shewchuk Line = papers co-authored together Lisa M. Shewchuk links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	GSK114: A selective inhibitor for elucidating the biological role of TNNI3K Bioorganic & Medicinal Chemistry Letters ·Brian G. Lawhorn,Joanne Philp,Alan P. Graves,Lisa M. Shewchuk,Dennis A. Holt,Gregory J. Gatto,Lara S. Kallander	2016	13
2	Impact of Common Epidermal Growth Factor Receptor and HER2 Variants on Receptor Activity and Inhibition by Lapatinib Cancer Research ·Tona M. Gilmer,LouAnn Cable,Krystal J. Alligood,David W. Rusnak,Glenn Spehar,Kathleen T. Gallagher,Ermias Woldu,H. Luke Carter,Anne T. Truesdale,Lisa M. Shewchuk,Edgar R. Wood	2008	51
3	Imidazo[5,1-f][1,2,4]triazin-2-amines as novel inhibitors of polo-like kinase 1 Bioorganic & Medicinal Chemistry Letters ·Mui Cheung,Kevin W. Kuntz,Mark A. Pobanz,James M. Salovich,Bart J. Wilson,C. Webster Andrews,Lisa M. Shewchuk,Andrea H. Epperly,Daniel F. Hassler,M. Anthony Leesnitzer,Jeffery L. Smith,Gail K. Smith,Timothy J. Lansing,Robert A. Mook	2008	9
4	5-(1H-Benzimidazol-1-yl)-3-alkoxy-2-thiophenecarbonitriles as potent, selective, inhibitors of IKK-ε kinase Bioorganic & Medicinal Chemistry Letters ·Paul Bamborough,J.A. Christopher,Geoffrey J. Cutler,Marion C. Dickson,Geoffrey W. Mellor,J. V. Morey,Champa Patel,Lisa M. Shewchuk	2006	43
5	Novel, potent P2–P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors Bioorganic & Medicinal Chemistry Letters ·David G. Barrett,John G. Catalano,David N. Deaton,Anne M. Hassell,Stacey T. Long,Aaron B. Miller,Larry R. Miller,John A. Ray,Vicente Sámano,Lisa M. Shewchuk,Kevin J. Wells‐Knecht,Derril H. Willard,Lois L. Wright	2006	16
6	Crystallization of protein–ligand complexes Acta Crystallographica Section D Biological Crystallography ·Anne M. Hassell,Gang An,Randy K. Bledsoe,Jane M. Bynum,H. Luke Carter,Su-Jun Deng,Robert T. Gampe,Tamara E. Grisard,Kevin P. Madauss,Robert T. Nolte,Warren J. Rocque,Liping Wang,Kurt Weaver,Shawn P. Williams,G. Bruce Wisely,Robert X. Xu,Lisa M. Shewchuk	2006	120
7	Novel and potent cyclic cyanamide-based cathepsin K inhibitors Bioorganic & Medicinal Chemistry Letters ·David N. Deaton,Anne M. Hassell,Robert B. McFadyen,Aaron B. Miller,Larry R. Miller,Lisa M. Shewchuk,Francis X. Tavares,Derril H. Willard,Lois L. Wright	2005	31
8	Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors? Bioorganic & Medicinal Chemistry Letters ·Kim K. Adkison,David G. Barrett,David N. Deaton,Robert T. Gampe,Anne M. Hassell,Stacey T. Long,Robert B. McFadyen,Aaron B. Miller,Larry R. Miller,J. Alan Payne,Lisa M. Shewchuk,Kevin J. Wells‐Knecht,Derril H. Willard,Lois L. Wright	2005	12
9	A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)breakdown → Cancer Research ·Edgar R. Wood,Anne T. Truesdale,Octerloney B. McDonald,Derek Yuan,Anne M. Hassell,Scott H. Dickerson,Byron Ellis,Christopher Pennisi,Earnest Horne,Karen Lackey,Krystal J. Alligood,David W. Rusnak,Tona M. Gilmer,Lisa M. Shewchuk	2004	881
10	Potent and selective P2–P3 ketoamide inhibitors of cathepsin K with good pharmacokinetic properties via favorable P1′, P1, and/or P3 substitutions Bioorganic & Medicinal Chemistry Letters ·David G. Barrett,John G. Catalano,David N. Deaton,Anne M. Hassell,Stacey T. Long,Aaron B. Miller,Larry R. Miller,Lisa M. Shewchuk,Kevin J. Wells‐Knecht,Derril H. Willard,Lois L. Wright	2004	24
11	Exploration of the P2–P3 SAR of aldehyde cathepsin K inhibitors Bioorganic & Medicinal Chemistry Letters ·Eric E. Boros,David N. Deaton,Anne M. Hassell,Robert B. McFadyen,Aaron B. Miller,Larry R. Miller,Margot G. Paulick,Lisa M. Shewchuk,James B. Thompson,Derril H. Willard,Lois L. Wright	2004	27
12	アルデヒド系カテプシンK阻害剤のP 1 部位SAR探究 Bioorganic & Medicinal Chemistry Letters ·John G. Catalano,David N. Deaton,Eric S. Furfine,Anne M. Hassell,Robert B. McFadyen,Larry R. Miller,Lisa M. Shewchuk,Derril H. Willard,Lois L. Wright	2004	26
13	Exploration of the P1 SAR of aldehyde cathepsin K inhibitors Bioorganic & Medicinal Chemistry Letters ·John G. Catalano,David N. Deaton,Eric S. Furfine,Annie M. Hassell,Robert B. McFadyen,Aaron B. Miller,Larry R. Miller,Lisa M. Shewchuk,Derril H. Willard,Lois L. Wright	2003	32
14	Anilinopyrazole as selective CDK2 inhibitors Bioorganic & Medicinal Chemistry Letters ·Jun Tang,Lisa M. Shewchuk,Hideyuki Sato,Masaichi Hasegawa,Yoshiaki Washio,Naohiko Nishigaki	2003	34
15	The Drosophila Orphan Nuclear Receptor DHR38 Mediates an Atypical Ecdysteroid Signaling Pathway Cell ·K.D. Baker,Lisa M. Shewchuk,Tatiana Kozlova,Makoto Makishima,Annie M. Hassell,Bruce Wisely,Justin A. Caravella,Millard H. Lambert,Jeffrey Reinking,Henry M. Krause,Carl S. Thummel,Timothy M. Willson,David J. Mangelsdorf	2003	182
16	Structure of the Tie2 RTK Domain Structure ·Lisa M. Shewchuk,Anne M. Hassell,Byron Ellis,William D. Holmes,Roderick Davis,Earnest Horne,Sue H. Kadwell,David D. McKee,John T. Moore	2000	113
17	The formation of a covalent complex between a dipeptide ligand and the src SH2 domain Bioorganic & Medicinal Chemistry Letters ·Krystal J. Alligood,Paul S. Charifson,Renae M. Crosby,Thomas G. Consler,Paul L. Feldman,Robert T. Gampe,Tona M. Gilmer,Steven R. Jordan,Mark W. Milstead,Christopher Mohr,Michael Peel,Warren J. Rocque,Marc Rodriguez,David W. Rusnak,Lisa M. Shewchuk,Daniel D. Sternbach	1998	13
18	Structure of a hinge-bending bacteriophage T4 lysozyme mutant, Ile3 → Pro Journal of Molecular Biology ·M.M. Dixon,H. Nicholson,Lisa M. Shewchuk,W.A. Baase,Brian W. Matthews	1992	69
19	Transcriptional switching by the MerR protein: activation and repression mutants implicate distinct DNA and mercury(II) binding domains Biochemistry ·Lisa M. Shewchuk,John D. Helmann,Wilma Ross,Soon‐Jung Park,Anne O. Summers,Christopher T. Walsh	1989	50
20	Transcriptional switching by the metalloregulatory MerR protein: initial characterization of DNA and mercury(II) binding activities Biochemistry ·Lisa M. Shewchuk,Gregory L. Verdine,C T Walsh	1989	55

About Lisa M. Shewchuk

Lisa M. Shewchuk is a scholar working on Immunology and Allergy, Physiology and Oncology, having authored 45 papers that have together received 3.0k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (8 papers), Signaling Pathways in Disease (6 papers), Natural product bioactivities and synthesis (5 papers), Enzyme Structure and Function (5 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), HER2/EGFR in Cancer Research (4 papers), Cancer-related Molecular Pathways (4 papers) and Cell Adhesion Molecules Research (4 papers). The work is most often cited by research in Oncology (899 citations), Organic Chemistry (690 citations) and Molecular Biology (1.6k citations). Lisa M. Shewchuk has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Anne M. Hassell, Byron Ellis, David W. Rusnak, Edgar R. Wood, Anne T. Truesdale, Krystal J. Alligood, Tona M. Gilmer, Karen Lackey, Scott H. Dickerson and Octerloney B. McDonald. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact